JPS61134314A - 獣医薬鎮静鎮痛剤 - Google Patents
獣医薬鎮静鎮痛剤Info
- Publication number
- JPS61134314A JPS61134314A JP60272380A JP27238085A JPS61134314A JP S61134314 A JPS61134314 A JP S61134314A JP 60272380 A JP60272380 A JP 60272380A JP 27238085 A JP27238085 A JP 27238085A JP S61134314 A JPS61134314 A JP S61134314A
- Authority
- JP
- Japan
- Prior art keywords
- formula
- sedative
- compound
- analgesic
- xylazine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000001624 sedative effect Effects 0.000 title claims description 14
- 239000000932 sedative agent Substances 0.000 title claims description 11
- 230000000202 analgesic effect Effects 0.000 title description 7
- 239000000730 antalgic agent Substances 0.000 claims abstract description 5
- CUHVIMMYOGQXCV-UHFFFAOYSA-N medetomidine Chemical compound C=1C=CC(C)=C(C)C=1C(C)C1=CNC=N1 CUHVIMMYOGQXCV-UHFFFAOYSA-N 0.000 claims abstract 2
- 241001465754 Metazoa Species 0.000 claims description 9
- 241000282472 Canis lupus familiaris Species 0.000 claims description 5
- 241000282326 Felis catus Species 0.000 claims description 5
- 241000700198 Cavia Species 0.000 claims description 3
- 241000283973 Oryctolagus cuniculus Species 0.000 claims description 3
- 239000004480 active ingredient Substances 0.000 claims description 2
- 241000124008 Mammalia Species 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 description 16
- 229960001600 xylazine Drugs 0.000 description 9
- BPICBUSOMSTKRF-UHFFFAOYSA-N xylazine Chemical compound CC1=CC=CC(C)=C1NC1=NCCCS1 BPICBUSOMSTKRF-UHFFFAOYSA-N 0.000 description 9
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 6
- 230000000694 effects Effects 0.000 description 5
- 238000001990 intravenous administration Methods 0.000 description 4
- 150000002460 imidazoles Chemical class 0.000 description 3
- 238000007918 intramuscular administration Methods 0.000 description 3
- 241000283690 Bos taurus Species 0.000 description 2
- 229940035676 analgesics Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 229940030600 antihypertensive agent Drugs 0.000 description 1
- 239000002220 antihypertensive agent Substances 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- RHDJRPPFURBGLQ-UHFFFAOYSA-N detomidine Chemical compound CC1=CC=CC(CC=2NC=NC=2)=C1C RHDJRPPFURBGLQ-UHFFFAOYSA-N 0.000 description 1
- 231100000673 dose–response relationship Toxicity 0.000 description 1
- 230000000147 hypnotic effect Effects 0.000 description 1
- 230000010255 response to auditory stimulus Effects 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 229940125723 sedative agent Drugs 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Photoreceptors In Electrophotography (AREA)
- Stringed Musical Instruments (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI844786A FI844786A0 (fi) | 1984-12-04 | 1984-12-04 | Terapeutiskt utnyttjbar foerening. |
| FI844786 | 1984-12-04 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS61134314A true JPS61134314A (ja) | 1986-06-21 |
| JPH0465050B2 JPH0465050B2 (enExample) | 1992-10-16 |
Family
ID=8520010
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP60272380A Granted JPS61134314A (ja) | 1984-12-04 | 1985-12-03 | 獣医薬鎮静鎮痛剤 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US4670455A (enExample) |
| EP (1) | EP0187471B1 (enExample) |
| JP (1) | JPS61134314A (enExample) |
| AT (1) | ATE65694T1 (enExample) |
| AU (1) | AU572364B2 (enExample) |
| DE (1) | DE3583670D1 (enExample) |
| DK (1) | DK163960C (enExample) |
| FI (1) | FI844786A0 (enExample) |
| IE (1) | IE58269B1 (enExample) |
| NZ (1) | NZ213604A (enExample) |
| ZA (1) | ZA858416B (enExample) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS63135330A (ja) * | 1986-11-11 | 1988-06-07 | ファルモス−ユヒチュメ・オユ | 不安症治療剤 |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2206880B (en) | 1987-07-16 | 1991-04-24 | Farmos Oy | Optical isomers of an imidazole derivative |
| US5344840A (en) * | 1988-02-29 | 1994-09-06 | Orion-Yhtyma Oy | 4-substituted imidazole derivatives useful in perioperative care |
| GB2215206B (en) | 1988-02-29 | 1991-07-03 | Farmos Oy | 4-substituted imidazole derivatives useful in perioperative care |
| US5124157A (en) * | 1989-08-18 | 1992-06-23 | Cygnus Therapeutic Systems | Method and device for administering dexmedetomidine transdermally |
| AR015744A1 (es) * | 1998-04-01 | 2001-05-16 | Orion Corp | Uso de dexmedetomidina para sedacion en terapia intensiva |
| FI20041425A0 (fi) * | 2004-11-05 | 2004-11-05 | Orion Corp | Transmukosaalinen veterinäärinen koostumus |
| US7795263B2 (en) * | 2008-07-08 | 2010-09-14 | Wildlife Laboratories, Inc. | Pharmaceutical combination for and method of anesthetizing and immobilizing non-domesticated mammals |
| EP2370136A4 (en) * | 2008-12-01 | 2015-12-30 | Map Pharmaceuticals Inc | INHALATIVE RELEASE PROCEDURES AND DEVICES |
| WO2010074753A1 (en) * | 2008-12-23 | 2010-07-01 | Map Pharmaceuticals, Inc. | Inhalation devices and related methods for administration of sedative hypnotic compounds |
| US20130096170A1 (en) | 2011-10-14 | 2013-04-18 | Hospira, Inc. | Methods of treating pediatric patients using dexmedetomidine |
| WO2013069025A1 (en) | 2011-11-11 | 2013-05-16 | Neon Laboratories Ltd. | "process for the preparation of dexmedetomidine" |
| US8242158B1 (en) | 2012-01-04 | 2012-08-14 | Hospira, Inc. | Dexmedetomidine premix formulation |
| CN105764496B (zh) | 2013-10-07 | 2020-09-25 | 帝国制药美国公司 | 用于经皮递送非镇静量的右旋美托咪啶的方法和组合物 |
| TWI709417B (zh) | 2013-10-07 | 2020-11-11 | 美商帝國製藥美國股份有限公司 | 使用右美托咪啶經皮組成物用於治療注意力不足過動症、焦慮及失眠的方法及組成物 |
| TWI704933B (zh) | 2013-10-07 | 2020-09-21 | 美商帝國製藥美國股份有限公司 | 右美托咪啶經皮輸送裝置及使用其之方法 |
| US9717796B1 (en) | 2016-04-20 | 2017-08-01 | Slypharma, Llc | Heat sterilizeable, premixed, ready to use dexmedetomidine solution packaged in a flexible plastic container |
| CA3045043A1 (en) | 2016-12-31 | 2018-07-05 | Bioxcel Therapeutics, Inc. | Use of sublingual dexmedetomidine for the treatment of agitation |
| CN115154440A (zh) | 2018-06-27 | 2022-10-11 | 比奥克斯塞尔医疗股份有限公司 | 含右美托咪定的膜制剂及其制造方法 |
| US11160791B2 (en) | 2018-11-01 | 2021-11-02 | Medefil, Inc. | Dexmedetomidine injection premix formulation in ready to use (RTU) bags |
| WO2021016112A2 (en) | 2019-07-19 | 2021-01-28 | Bioxcel Therapeutics, Inc. | Non-sedating dexmedetomidine treatment regimens |
| US11806334B1 (en) | 2023-01-12 | 2023-11-07 | Bioxcel Therapeutics, Inc. | Non-sedating dexmedetomidine treatment regimens |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2092569B (en) * | 1981-02-05 | 1984-09-19 | Farmos Oy | Substituted imidazole derivatives and their preparation and use |
| GB2096987B (en) * | 1981-04-22 | 1984-04-04 | Farmos Oy | Substituted imidazole and imidazole derivatives and their preparation and use |
| GB2101114B (en) * | 1981-07-10 | 1985-05-22 | Farmos Group Ltd | Substituted imidazole derivatives and their preparation and use |
| GR77568B (enExample) * | 1982-08-14 | 1984-09-24 | Wellcome Found |
-
1984
- 1984-12-04 FI FI844786A patent/FI844786A0/fi not_active Application Discontinuation
-
1985
- 1985-09-25 NZ NZ213604A patent/NZ213604A/xx unknown
- 1985-11-01 ZA ZA858416A patent/ZA858416B/xx unknown
- 1985-11-05 DK DK508985A patent/DK163960C/da not_active IP Right Cessation
- 1985-11-15 AU AU49971/85A patent/AU572364B2/en not_active Expired
- 1985-12-02 EP EP85308748A patent/EP0187471B1/en not_active Expired - Lifetime
- 1985-12-02 DE DE8585308748T patent/DE3583670D1/de not_active Expired - Lifetime
- 1985-12-02 IE IE302485A patent/IE58269B1/en not_active IP Right Cessation
- 1985-12-02 AT AT85308748T patent/ATE65694T1/de not_active IP Right Cessation
- 1985-12-03 JP JP60272380A patent/JPS61134314A/ja active Granted
- 1985-12-03 US US06/804,197 patent/US4670455A/en not_active Expired - Lifetime
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS63135330A (ja) * | 1986-11-11 | 1988-06-07 | ファルモス−ユヒチュメ・オユ | 不安症治療剤 |
Also Published As
| Publication number | Publication date |
|---|---|
| ZA858416B (en) | 1986-07-30 |
| DE3583670D1 (de) | 1991-09-05 |
| ATE65694T1 (de) | 1991-08-15 |
| US4670455A (en) | 1987-06-02 |
| JPH0465050B2 (enExample) | 1992-10-16 |
| DK508985A (da) | 1986-06-05 |
| IE853024L (en) | 1986-06-04 |
| DK163960B (da) | 1992-04-27 |
| NZ213604A (en) | 1988-09-29 |
| EP0187471A3 (en) | 1988-09-14 |
| DK163960C (da) | 1992-09-21 |
| FI844786A0 (fi) | 1984-12-04 |
| AU4997185A (en) | 1986-06-12 |
| DK508985D0 (da) | 1985-11-05 |
| IE58269B1 (en) | 1993-08-25 |
| EP0187471A2 (en) | 1986-07-16 |
| EP0187471B1 (en) | 1991-07-31 |
| AU572364B2 (en) | 1988-05-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPS61134314A (ja) | 獣医薬鎮静鎮痛剤 | |
| Wagner et al. | Use of low doses of ketamine administered by constant rate infusion as an adjunct for postoperative analgesia in dogs | |
| US5849737A (en) | Compositions and methods for treating pain | |
| DE60101265T2 (de) | Behandlung von augenschmerzen | |
| JPH06507392A (ja) | 交感神経性の持続性疼痛の治療のための組成物および方法 | |
| JP2002515438A (ja) | 局所的な無痛のための三環式抗鬱薬の使用 | |
| USRE41998E1 (en) | Compositions and methods of treatment of sympathetically maintained pain | |
| SK127896A3 (en) | Use of serotonin antagonists (5ht3) for treating fibromyalgia | |
| CA2303815A1 (en) | N,n-bis (phenylcarbamoylmethyl) dimethylammonium chloride and derivatives in the treatment of pain | |
| KR20150080016A (ko) | (티오)-카르바모일-시클로헥산 유도체 및 정신분열 치료 방법 | |
| JP2022116304A (ja) | 血液がんの治療のためのＰＰＡＲγアゴニスト | |
| TW201536295A (zh) | σ配體在與間質性膀胱炎／膀胱疼痛綜合徵（ＩＣ／ＢＰＳ）相關的疼痛的預防和治療中的應用 | |
| JP4867123B2 (ja) | 神経因性疼痛治療剤および神経因性疼痛のモデル動物 | |
| RU2759726C2 (ru) | Дексмедетомидин или медетомидин для применения для лечения сепарационной тревожности у собак | |
| US5629336A (en) | Use of glycine/NMDA receptor ligands for the treatment of drug dependence and withdrawal | |
| DE69003924T2 (de) | Verhinderung von Entzugserscheinungen. | |
| ES2322954T3 (es) | Agonistas del adrenoceptor alfa 2b o 2b/2c para el tratamiento de la enfermedad de alzheimer y la enfermedad de parkinson. | |
| CN114288289A (zh) | 具有镇痛和/或止痒功能的药物组合物及其应用 | |
| KR19990036248A (ko) | 마약성 진통제의 의존·내성 형성 억제제 | |
| JP2000501709A (ja) | 疼痛治療用組成物 | |
| WO1990000390A1 (en) | New synergistic preparations containing dezocine and a local anaesthetic and a new method of alleviation of pain | |
| EP0542988B1 (en) | Improved euthanasia compositions | |
| CN110613713A (zh) | 3-羟基氨基苯甲酸与索拉非尼联合用药治疗肿瘤 | |
| JP2002308769A (ja) | 止痒剤 | |
| US3845192A (en) | Use of analgesic compositions |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| EXPY | Cancellation because of completion of term |